Lesch, M., Luckner, M., Meyer, M., Weege, F., Gravenstein, I., Raftery, M., et al. (2019). RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals. PLoS Pathogens, 15(3): e1007601. doi:10.1371/journal.ppat.1007601.